SONN
Sonnet BioTherapeutics Holdings Inc. · NASDAQ
Sonnet BioTherapeutics Holdings Inc. (SONN) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for SONN in the last 30 days. The most recent was published Dec 17, 2025.
Latest news
25 items- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
- SECSEC Form EFFECT filed by Sonnet BioTherapeutics Holdings Inc.EFFECT - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Filer)
SONN FAQ
7 questionsWhat does Sonnet BioTherapeutics Holdings Inc. do?
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for...What is the latest news on SONN?
Quantisnow has not tracked any new filings, ratings or press releases for SONN in the last 30 days. The most recent wire item was published on December 17, 2025.Where does SONN stock trade?
Sonnet BioTherapeutics Holdings Inc. (SONN) is listed on NASDAQ.What sector and industry is SONN in?
Sonnet BioTherapeutics Holdings Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about SONN?
Sonnet BioTherapeutics Holdings Inc. has had 4 recent analyst actions on file. The most recent action was from BTIG: Buy with a $2.00 price target on 2022-02-09. Recent price targets range from $2.00 to $5.00.What companies are similar to SONN?
Notable peers in the same industry include JNJ (Johnson & Johnson), MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), ABT (Abbott Laboratories). Compare SONN side-by-side with any of them on Quantisnow.How can I track SONN on Quantisnow?
Quantisnow aggregates Sonnet BioTherapeutics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SONN to receive live email and push alerts on every new disclosure.